Stay updated on Optimal Tenecteplase Dose in Stroke Clinical Trial
Sign up to get notified when there's something new on the Optimal Tenecteplase Dose in Stroke Clinical Trial page.

Latest updates to the Optimal Tenecteplase Dose in Stroke Clinical Trial page
- Check2 days agoChange DetectedThe clinical trial record for the EXTEND-IA TNK Part 2 study is available, including its tenecteplase treatment arms, eligibility criteria, outcomes, locations, and related publications.SummaryDifference60%

- Check9 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.2 to v3.8.0 while the page continued to display a 403 error.SummaryDifference0.2%

- Check16 days agoChange DetectedA site-wide notice announces changes to NIH websites and says that “Super Intelligence” may appear in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check23 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check30 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check50 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the previous study details. This indicates the page is currently inaccessible and no trial information is visible.SummaryDifference18%

Stay in the know with updates to Optimal Tenecteplase Dose in Stroke Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Optimal Tenecteplase Dose in Stroke Clinical Trial page.